Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-04-17
DOI
https://doi.org/10.3324/haematol.2024.287047
Citations
3
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma

Ingrid Quist-Løkken, Toril Holien, Anders Sundan, Felix Hausch et al.
3 citations
Haematologica
Protein Degradation and Inhibitors
2.42
article

Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma

Ingrid Quist-Løkken, Toril Holien, Anders Sundan, Felix Hausch, Clara Andersson-Rusch, Tobias S. Slørdahl, Md Abu Hanif, Michael Walz, Mira Tilseth, Johanna Fredrikke Nordstrand Moen, Megan Anne Vik
article en
3 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 110(10)
Norwegian University of Science and Technology (NO), Technische Universität Darmstadt (DE)
Zero hunger
Openalex Percentile: Top 12%
Protein Degradation and Inhibitors
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma — Ingrid Quist-Løkken, Toril Holien, et al. · Haematologica (2025) | TGRS Research Map | TGRS